Bone Grafting and Alternatives Market Growth, Size, And Statistics Forecasts Up To 2030

SDKI Inc. published a new report on the global bone graft and replacement market on November 18, 2021. This study includes the statistical and analytical approaches needed to grow the bone graft and alternatives market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-58768

The bone graft and alternatives market is estimated to grow from a market value of US $ 3,244.8 million in 2022 to US $ 4,505.3 million by 2030, with a CAGR of 4.80% during the 2022-2030 forecast period.

Bone grafts stimulate bone formation, bone healing, bone reconstruction, etc. It is a transplantable material used for. These bone graft materials are used in surgical procedures (bone grafts) known as bone grafts to replace missing bone with these materials. They are used in sports, trauma, plastic, facial, and spinal surgery. In addition, it can be used to fill gaps and provide structural stability in the absence of bone. The rising incidence of musculoskeletal disorders and the growing foundation of the elderly population are driving the demand for bone grafts in treatment. In addition, technological advances and rising rates of diabetes and obesity are contributing to the growth of the bone graft and alternatives market.

Bone disorders are common in the elderly due to their low bone density. The number of Americans aged 65 and over is estimated to be about 46 million in 2016, and is expected to reach about 98 million by 2060. In 2015, 8.5% of the world's total population (617 million) was 65 or older, according to the National Institutes of Health. This aging population is also projected to reach about 1.6 billion by the end of 2050. This is expected to drive the growth of the bone graft and alternatives market. However, the high cost of surgery can hinder the growth of the bone graft and replacement market during the 2022-2030 forecast period.

The overall impact of the COVID-19 pandemic could remain negative for medical device companies in the bone graft and replacement industry. The blockage is facing recession for companies, which has led to disruption in supply chain activities around the world. In addition, key players in the industry are facing issues regarding the availability of human resources to manufacture bone grafts and alternatives at production facilities. End users, such as hospitals and clinics, also reported that blockage restrictions in place around the world reduced patient consultations.

Report sample URL
https://www.sdki.jp/sample-request-58768

Bone Grafting / Alternatives Market Segment

The bone grafting / alternatives market is by product (allogeneic graft, bone graft alternatives, cell-based matrix (CBM)) and application (spine fusion, traumatic craniofacial surgery, joint reconstruction). , Dental bone grafting), and divided by region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.